Knobias Clip Report (02-20-2008)
Submitted By Knobias ClipReport
EFSF: Management Provides Update on Citroxin(TM) and Other Promising Products
Management of eFoodSafety.com, Inc. (EFSF) recently attended the Bangkok International Conference on Avian Influenza 2008. eFoodSafety’s Citroxin(TM) is currently undergoing testing at Chulalongkorn University, Thailand, on a chick embryo model, for the product’s ability to safely and effectively eradicate the most virulent form of the bird flu, the H5N1 virus.
Mr. Timothy Matula, Director and Corporate Secretary of eFoodSafety, told Knobias on Wednesday, “We received a great response. There were over eight hundred conference attendees from around the world, and the most rewarding parts of the conference were the times we could speak to people one-on-one. It was an unbelievable networking and knowledge sharing opportunity. We met people who were truly interested in our products and through our contacts we were introduced to people with whom we can work going forward.”
Of the avian influenza viruses that have crossed the species barrier to infect humans, H5N1 has caused the largest number of detected cases of severe disease and death in humans. Of the human cases associated with the ongoing H5N1 outbreaks, more than half of those people infected with the virus have died. Most cases have occurred in previously healthy children and young adults and have resulted from direct or close contact with H5N1-infected poultry or H5N1-contaminated surfaces.
Mr. Matula noted, “Many people do not understand that the H5N1 virus is alive and well and has re-surfaced in the Asian region.”
Citroxin(TM) is an environmentally safe product formulated entirely of food-grade components. In Environmental Protection Agency (EPA) required laboratory tests, Citroxin showed a 100% kill rate for the “big six” bacterial health threats that include E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, as well as Avian Influenza and Black Mold.”
Mr. Matula explained, “Citroxin and its sister products are being tested in numerous fashions through independent and well respected labs. Our testing methodologies are strong enough to demonstrate results that will be acceptable to the scientific community and then warrant further Phase II and possibly Phase III studies. Virtually no natural products go through this level of clinical testing.”
“Market opportunities are vast for Citroxin. There are very few products that effectively treat viruses. Those that are natural are limited from an efficacy standpoint and not well researched as final formulations. Allopathic products do not have a very strong efficacy rating statistically. Often the side effects are as bad as the disease being treated. Citroxin has no known side effects when used according to specifications. We focus on products that will have mass market potential. We have shown positive results through testing on H5N1, Malaria, Tuberculosis, MRSA Staph, E-coli, and Listeria. The market potential for a breakthrough treatment in any of these markets presents a huge opportunity for the company.”
Some of the other products in the Company’s pipeline include an anthrax sporicidal; Auromoxin for malaria; Cinnechol, an all natural nutritional supplement designed to reduce total cholesterol level; Occusyn for Lyme disease; OraPhyte to eradicate nematodes (parasites); PurEffect acne treatment; and Trimyacin for the Tuberculosis organism.
“There are many products that are available for these conditions. Most competitors, however, are companies that create treatments using non-natural ingredients. eFoodSafety uses natural ingredients and this is what sets us dramatically apart. Our formulations employ novel ingredients, ingredient synergies, state-of-the-art technologies, clinical testing, and research and development to produce cutting-edge products. We believe that more and more consumers are searching for natural remedies to heal their health ailments. We feel that eFoodSafety has and will be setting the bar for excellence in both ingestible and topical products. Our philosophy is to create product formulations that are considered original and unique,” commented Mr. Matula.
Products that are currently marketed by the Company include Cinnergen(TM), a liquid whole food supplement that provides vital nutrients essential for metabolizing and normalizing blood sugar; Cinnergen Healing Cream, a non-toxic topical cream to repair skin problems, including sores and dryness, for patients with blood sugar level imbalances; Talsyn Scar Cream, a topical cream used for the management of keloids (raised, reddish scars that develop at the site of an injury), hypertrophic scars (a more common scar similar to keloids), erythema multiforme (a skin disorder resulting from an allergic reaction), and surgical incisions; and the Immune Boost(TM) Bar, an energy bar that enhances overall immune function and increases resistance to common viruses.
Mr. Matula added, “The Immune Boost(TM) Bar is our newest innovation. Preliminary feedback from retailers shows great potential for these energy bars, that are designed to strengthen the immune system in a convenient, tasty way. A March 2008 launch will feed into the energy bar market. The growth potential of this product can be likened to that of PowerBar(TM). Nestle(TM) acquired PowerBar(TM) at a time when PowerBar(TM) was showing roughly $140 million in revenue. The rumored sales price to Nestle(TM) was $375 million representing close to a three times premium over revenue. Creating brand recognition for Immune Boost(TM) Bar will be key to its success in the coming year as we build nationwide distribution with key mass market retailers.”
“We employ several marketing channels. We are currently in several thousand retail stores and eFoodSafety will be adding several thousand more retail stores in the coming months that will distribute current and new product lines. Direct response selling is another market venue for us. We are also very close to launching a national direct response campaign running on major cable and broadcast networks. Selling via the Internet is another distribution channel that we utilize.”
Mr. Matula concluded, “eFoodSafety recently achieved profitability on an operating basis, excluding R&D costs and stock for services expense. This is a monumental milestone for us. Our mission is to develop innovative products and technologies that improve health conditions and enhance the quality of food worldwide. Our company seeks to take advantage of the multi-million dollar markets available in the retail sector. We have positioned our unique products to compete with price, quality, and value in the retail arena.”
Visit 1800blogger to see all of our industry leading blogs.
